0RAE.LSE Amoeba S.A.
- Market cap
- EUR 5.52M
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Is 0RAE.LSE undervalued?
Graham numberThe Graham number of Amoeba S.A. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Amoeba S.A. fundamental analysis
No fundamental analysis for Amoeba S.A. yet.
Amoeba S.A. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Amoeba S.A.
Amoéba S.A. develops biological products and services for the treatment of microbiological risk in the sectors of water, health, and plant protection in France. The company has developed technology to treat water, surfaces, and chronic wounds that uses the natural biocidal capacity of the living amoeba Willaertia magna C2c Maky; and agriculture biocontrol technology for the treatment of phytopathogenic microorganisms using the lysed. Amoéba S.A. was incorporated in 2010 and …
Full company profileFinancial statements of Amoeba S.A. are not available yet.
Amoeba S.A. dividends
Amoeba S.A. has not paid dividends in the last 4 fiscal years.
Who owns Amoeba S.A.
- Insiders 13.78%
- Institutions 0.40%
- Public & others 85.83%
- Shares outstanding 6.01M
- Free float 68.9M
Amoeba S.A. company profile
- Company name
- Amoeba S.A.
- Ticker
- 0RAE.LSE
- ISIN
- FR0011051598
- Exchange
- London Exchange
- Sector
- Basic Materials
- Industry
- Oil, Gas & Consumable Fuels
- Employees
- 23
- Fiscal year end
- December
- Address
- 38 Avenue des FrEres Montgolfier, Chassieu, France, 69680
- Phone
- 33 4 26 69 16 00
- Website
- amoeba-nature.com
About Amoeba S.A.
Amoéba S.A. develops biological products and services for the treatment of microbiological risk in the sectors of water, health, and plant protection in France. The company has developed technology to treat water, surfaces, and chronic wounds that uses the natural biocidal capacity of the living amoeba Willaertia magna C2c Maky; and agriculture biocontrol technology for the treatment of phytopathogenic microorganisms using the lysed. Amoéba S.A. was incorporated in 2010 and is headquartered in Chassieu, France.
Amoeba S.A. management
3- Mr. Jean-Francois DoucetGeneral Director
- Mr. Jean-Marc PetatMD of Green 4 Agro & Director · born 1964
- Dr. Sandrine TroussieuxScientific Director